Drug Database
Molecular
Expressions: The Pharmaceutical Collection - dopamine
Ferreira, A., Bettencourt, P., Pimenta, J., Frioes, F., Pestana, M., Soares-da,
S. P., et al. (2002, Mar). The renal dopaminergic system, neurohumoral activation,
and sodium handling in heart failure. American Heart Journal., 143(3), 391-7.
Gagnon, F., Hamet, P., & Orlov, S. (1999, May). Na+,K+ pump and Na+-coupled
ion carriers in isolated mammalian kidney epithelial cells: Regulation by protein
kinase C. [Review] [71 refs]. Canadian Journal of Physiology & Pharmacology.,
77(5), 305-19.
Leier, C., & Binkley, P. (1998, Nov-Dec.). Parenteral inotropic support
for advanced congestive heart failure. [Review] [111 refs]. Progress in Cardiovascular
Diseases., 41(3), 207-24.
Mabuchi, N., Tsutamoto, T., & Kinoshita, M. (2000). Therapeutic use of dopamine
and beta-blockers modulates plasma interleukin-6 levels in patients with congestive
heart failure. Journal of Cardiovascular Pharmacology., 36(Suppl 2), S87-91.
Smit, A. (2000, Apr). Dopamine in heart failure and critical care. [Review]
[23 refs]. Clinical & Experimental Hypertension (New York), 22(3), 269-76.
Soares-da, S. P., Pestana, M., Ferreira, A., Damasceno, A., Polonia, J., &
Cerqueira-Gomes, M. (2000, Apr). Renal dopaminergic mechanisms in renal parenchymal
diseases, hypertension, and heart failure. [Review] [46 refs]. Clinical &
Experimental Hypertension (New York), 22(3), 251-68.
van Veldhuisen, D., & Poole-Wilson, P. (2001, Aug). The underreporting of
results and possible mechanisms of 'negative' drug trials in patients with chronic
heart failure. [Review] [67 refs]. International Journal of Cardiology., 80(1),
19-27.
Velasco, M., & Luchsinger, A. (1998, Jan). Dopamine: Pharmacologic and therapeutic
aspects. [Review] [52 refs]. American Journal of Therapeutics., 5(1), 37-43.